Table 1.
Not listed (n=246) |
Listed or Transplanted (n=63) |
p-value |
|
---|---|---|---|
Age, years | 46 +/− 9.2 | 44.2 +/− 8.8 | 0.2 |
Male gender | 175 (71.1%) | 47 (74.6%) | 0.6 |
Race Black White Other |
162/210 (77.1%) 47/210 (22.4%) 1/210 (0.5%) |
38/58 (65.5%) 18/58 (31.0%) 2/58 (3.5%) |
0.06 |
Hispanic ethnicity | 36/198 (18.2%) | 11/52 (21.2%) | 0.6 |
Currently employed | 55/216 (25.5%) | 13/55 (23.6%) | 0.8 |
Education beyond high school | 27/166 (16.3%) | 12/45 (26.7%) | 0.1 |
Married | 38/209 (18.2%) | 16/58 (27.6%) | 0.1 |
Dialysis modality Hemodialysis Peritoneal dialysis Pre-emptive evaluation |
183/209 (87.6%) 16/209 (7.7%) 10/209 (4.8%) |
49/54 (90.7%) 2/54 (3.7%) 3/54 (5.6%) |
0.6 |
Time on dialysis < 1 year 1–5 years > 5 years |
66/195 (33.9%) 86/195 (44.1%) 43/195 (22.1%) |
15/48 (31.3%) 21/48 (43.8%) 12/48 (25.0%) |
0.9 |
CD4, cells/dL | Median 343 (IQR 291) |
Median 461 (IQR 219) |
0.004 |
CD4 < 200 cells/dL | 32/141 (22.7%) | 1/57 (1.75%) | <0.0001 |
Detectable HIV viral load* | 44/145 (30.3%) | 8/57 (14.0%) | 0.02 |
Current antiretroviral therapy | 175/196 (89.3%) | 48/53 (90.6%) | 0.8 |
Hepatitis B or C co-infection | 90/213 (42.3%) | 27/60 (45.0%) | 0.7 |
History of illicit drug use | 102/205 (49.8%) | 18/52 (34.6%) | 0.05 |
Referring provider at same institution | 15/246 (6.1%) | 7/63 (12.5%) | 0.2 |
Based on the assay available at the time of evaluation.